218 related articles for article (PubMed ID: 35194156)
1. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.
Passweg JR; Baldomero H; Chabannon C; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; Mohty M; Neven B; Peffault de Latour R; Perić Z; Snowden JA; Yakoub-Agha I; Sureda A; Kröger N;
Bone Marrow Transplant; 2022 May; 57(5):742-752. PubMed ID: 35194156
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey.
Passweg JR; Baldomero H; Ciceri F; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; McLornan DP; Neven B; de Latour RP; Perić Z; Ruggeri A; Snowden JA; Sureda A
Bone Marrow Transplant; 2023 Jun; 58(6):647-658. PubMed ID: 36879108
[TBL] [Abstract][Full Text] [Related]
3. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT.
Passweg JR; Baldomero H; Ciceri F; de la Cámara R; Glass B; Greco R; Hazenberg MD; Kalwak K; McLornan DP; Neven B; Perić Z; Risitano AM; Ruggeri A; Snowden JA; Sureda A
Bone Marrow Transplant; 2024 Jun; 59(6):803-812. PubMed ID: 38438647
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.
Passweg JR; Baldomero H; Chabannon C; Basak GW; de la Cámara R; Corbacioglu S; Dolstra H; Duarte R; Glass B; Greco R; Lankester AC; Mohty M; Peffault de Latour R; Snowden JA; Yakoub-Agha I; Kröger N;
Bone Marrow Transplant; 2021 Jul; 56(7):1651-1664. PubMed ID: 33623153
[TBL] [Abstract][Full Text] [Related]
6. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.
Passweg JR; Baldomero H; Chabannon C; Basak GW; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Peffault de Latour R; Snowden JA; Styczynski J; Yakoub-Agha I; Kröger N;
Bone Marrow Transplant; 2020 Aug; 55(8):1604-1613. PubMed ID: 32066864
[TBL] [Abstract][Full Text] [Related]
7. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.
Passweg JR; Baldomero H; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Kuball J; Lankester A; Montoto S; de Latour RP; Snowden JA; Styczynski J; Yakoub-Agha I; Arat M; Mohty M; Kröger N;
Bone Marrow Transplant; 2019 Oct; 54(10):1575-1585. PubMed ID: 30728439
[TBL] [Abstract][Full Text] [Related]
8. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.
Passweg JR; Baldomero H; Bader P; Basak GW; Bonini C; Duarte R; Dufour C; Kröger N; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M;
Bone Marrow Transplant; 2018 Sep; 53(9):1139-1148. PubMed ID: 29540849
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Passweg JR; Baldomero H; Ansari M; Arber C; Chalandon Y; Daskalakis M; Diepold M; Diesch-Furlanetto T; Duchosal MA; Gerull S; Güngör T; Heim D; Hitz F; Holbro A; Masouridi-Levrat S; Nair G; Novak U; Pabst T; Renner C; Stussi G; Schneidawind D; Schanz U; Wannesson L; Halter JP;
Hematol Oncol; 2024 Jan; 42(1):e3241. PubMed ID: 38058031
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Al-Ramahi JS; Shahzad M; Li K; DeJarnette S; Chaudhary SG; Lutfi F; Ahmed N; Balusu R; Bansal R; Abdelhakim H; Shune L; Singh AK; Abhyankar SH; McGuirk JP; Mushtaq MU
Leuk Lymphoma; 2023 Dec; 64(12):1981-1991. PubMed ID: 37574842
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.
Xu LP; Lu DP; Wu DP; Jiang EL; Liu DH; Huang H; Sun ZM; Li NN; Liu QF; Zhang X; Lai YR; Song YP; Song XM; Liu SX; Zhang YC; Luo CJ; Xia LH; Niu T; Yu Y; Zhang XH; Tang XW; Luo Y; Huang XJ;
Transplant Cell Ther; 2023 Feb; 29(2):136.e1-136.e7. PubMed ID: 36402457
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.
Bazarbachi A; Labopin M; Ghavamzadeh A; Giebel S; Al-Zahrani H; Ladeb S; Leone G; Abdel-Rahman F; Liso V; Hamidieh AA; Rasheed W; Ibrahim A; Alabdulaaly A; Kyrcz-Krzemien S; Arnold R; Kharfan-Dabaja MA; Alimoghaddam K; Aljurf M; Mohty M
Bone Marrow Transplant; 2013 Aug; 48(8):1065-9. PubMed ID: 23353802
[TBL] [Abstract][Full Text] [Related]
16. Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012.
Correa C; Gonzalez-Ramella O; Baldomero H; Basquiera AL; Baena R; Arcuri L; Puga B; Rosales C; Chávez M; Hernández C; Maldonado B; Gómez-De León A; Mendoza N; Frutos C; Aranda L; Díaz L; Hernández M; Seber A; Karduss A; Jaimovich G; Martínez-Rolon J; Bonfim C; Greinix H; Koh MBC; Aljurf M; Iida M; Saber W; Niederwieser D; Atsuta Y; Galeano S; ;
Bone Marrow Transplant; 2022 Jun; 57(6):881-888. PubMed ID: 35347244
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic SCT in Europe: data and trends in 2011.
Passweg JR; Baldomero H; Bregni M; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Kröger N; Farge-Bancel D; Gaspar HB; Marsh J; Mohty M; Peters C; Sureda A; Velardi A; Ruiz de Elvira C; Madrigal A;
Bone Marrow Transplant; 2013 Sep; 48(9):1161-7. PubMed ID: 23584439
[TBL] [Abstract][Full Text] [Related]
18. The EBMT activity survey: 1990-2010.
Passweg JR; Baldomero H; Gratwohl A; Bregni M; Cesaro S; Dreger P; de Witte T; Farge-Bancel D; Gaspar B; Marsh J; Mohty M; Peters C; Tichelli A; Velardi A; de Elvira CR; Falkenburg F; Sureda A; Madrigal A;
Bone Marrow Transplant; 2012 Jul; 47(7):906-23. PubMed ID: 22543746
[TBL] [Abstract][Full Text] [Related]
19. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
Worel N; Shaw BE; Aljurf M; Koh M; Seber A; Weisdorf D; Schwartz J; Galeano S; Kodera Y; Eldridge PW; Hashmi S; Atsuta Y; Szer J; Saber W; Niederwieser D; Greinix HT;
Transplant Cell Ther; 2021 Mar; 27(3):270.e1-270.e6. PubMed ID: 33781537
[TBL] [Abstract][Full Text] [Related]
20. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
